With the equity markets edging nervously upwards again, but controlled fear still pervading the sector, is now a good time to launch a major venture capital (VC) fund for lifescience companies? Geoffrey Love, of The Wellcome Trust, believes it is. Addressing a press briefing on ...
Please Login to read the full article.
